Clearbridge Investments, LLC

Position in VKTX — Viking Therapeutics, Inc.

CIK 1348883 NEW YORK, NY

Position in VKTX

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$14,473,173

-$1,176,298 QoQ

Shares Held

444,781

-0.0% QoQ

Ownership

0.383%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Clearbridge Investments, LLC holds $2,718,012,251 across 26 Biotechnology names. VKTX ranks #18 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,700,975	$1,206,093,376
2	ALNY	Alnylam Pharmaceuticals, Inc.	1,356,036	$448,671,631
3	ARGX	Argenx SE	231,356	$168,947,719
4	TGTX	Tg Therapeutics, Inc.	3,210,930	$106,667,094
5	INSM	INSMED Inc	643,435	$105,214,491
6	BBIO	BridgeBio Pharma, Inc.	951,200	$70,636,112
7	PTGX	Protagonist Therapeutics, Inc	621,820	$65,539,828
8	MIRM	Mirum Pharmaceuticals, Inc.	671,870	$62,067,350

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$14,473,173	444,781	-0.0%	Shares	Sole	2026-05-13
2025-12-31	$15,649,471	444,840	+0.1%	Shares	Sole	2026-02-11
2025-09-30	$11,673,838	444,210	-29.6%	Shares	Sole	2025-11-13
2025-06-30	$16,730,854	631,353	-0.1%	Shares	Sole	2025-08-12
2025-03-31	$15,261,834	631,960	-1.3%	Shares	Sole	2025-05-13
2024-12-31	$25,758,348	640,118	-13.3%	Shares	Sole	2025-02-12
2024-09-30	$46,759,119	738,574	+26.3%	Shares	Sole	2024-11-12
2024-06-30	$30,989,699	584,601	-2.1%	Shares	Sole	2024-08-27
2024-03-31	$48,969,498	597,189	—	Shares	Sole	2024-05-13
No filing history on record for this holder in this stock.